Study: Routine genotyping demonstrates no benefit for antipsychotic outcome

* A randomized trial compared antipsychotic treatment outcomes among patients with schizophrenia whose treatment was guided by cytochrome P450 (CYP) testing, structured clinical monitoring, or usual clinical practice.

Saved in:
Bibliographic Details
Published inPsychopharmacology update Vol. 32; no. 4; p. 1
Main Authors Werge, Thomas, Jurgens, G, Andersen, S.E, Rasmussen, H.B
Format Journal Article
LanguageEnglish
Published Wiley Periodicals, Inc 01.04.2021
Subjects
Antipsychotic drugs
Comparative analysis
Cytochrome P-450
Physiological aspects
Schizophrenia
Online AccessGet full text

Cover

More Information
Summary:* A randomized trial compared antipsychotic treatment outcomes among patients with schizophrenia whose treatment was guided by cytochrome P450 (CYP) testing, structured clinical monitoring, or usual clinical practice.
ISSN:1068-5308
1556-7532
DOI:10.1001/jamanetworkopen.2020.27909